Jan Lenaerts

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

Joachim Sieper, Jan Lenaerts, J. Wollenhaupt et al. · Annals of the Rheumatic Diseases · 2013 · 210 citations · Full text

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2014 · 124 citations · Full text

Musculoskeletal Effects of the Recombinant Human IGF-I/IGF Binding Protein-3 Complex in Osteoporotic Patients with Proximal Femoral Fracture: A Double-Blind, Placebo-Controlled Pilot Study

Steven Boonen, Clifford J. Rosen, Roger Bouillon et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 115 citations · Full text

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2016 · 114 citations

Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases

Laurens De Sadeleer, Caressa Meert, Jonas Yserbyt et al. · CHEST Journal · 2018 · 105 citations · Full text

Advanced Lung Disease, Respiratory Diseases, Diagnosis +8